课题基金 / 基金详情

项目摘要

项目成果

STEVEN P STRATTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
9.2 Protocol Review and Monitoring System (PRMS) The Protocol Review and Monitoring System at the Arizona Cancer Center facilitates the our Scientific Review Committee (SRC), which is staffed with appropriate faculty and scientific representation in all disiciplines, to include but not be limited to medical hematology/oncology, surgical oncology, gynecologic oncology, radiafion oncology, pediatric hematology/oncology. Other medical subspecialities, cancer chemoprevention, and, translationals studies with clinical and basic science collaborators are also covered. The primary responsibilities of the AZCC SRC include the following: ¿ Review of all new hypothesis-generated interventional protocols of diagnostic or therapeutic nature as well as longitudinal population-based studies involving patients, patient samples, or patient records conducted by AZCC members to ensure the highest scientific quality of clinical research in advance of IRB submission. ¿ Review ongoing progress of protocols conducted by AZCC members to maximize scientific validity, assure timely and effective performance. - ¿ Evaluate the merit of eligible protocols for utilization of AZCC shared resources/services based upon objective scientific review. ¿ Promote unified standards for protocol implementation and translational research among AZCC investigators of various disciplines involved in cancer treatment and care. Regardless of the protocol type, no clinical research study eligible for SRC review can be submitted to the institutional IRB until SRC approval is granted. SRC actions and approval will accompany IRB submissions. In exceptional circumstances, concurrent IRB review may be allowed with written permission from the SRC Chairman.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
  • 批准号:
    8689936
  • 项目类别:
  • 资助金额:
    $5.18万
  • 财政年份:
    2013
  • 负责人:
    STEVEN P STRATTON
  • 依托单位:
Protocol Review and Monitoring
  • 批准号:
    7944595
  • 项目类别:
  • 资助金额:
    $7.56万
  • 财政年份:
    2009
  • 负责人:
    STEVEN P STRATTON
  • 依托单位:
Core--Drug Development
  • 批准号:
    6991771
  • 项目类别:
  • 资助金额:
    $20.82万
  • 财政年份:
    2004
  • 负责人:
    STEVEN P STRATTON
  • 依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
  • 批准号:
    6378120
  • 项目类别:
  • 资助金额:
    $11.01万
  • 财政年份:
    2000
  • 负责人:
    STEVEN P STRATTON
  • 依托单位:
海外基金